07.12.2012 Views

SAVE THE DATE - Hypoport AG

SAVE THE DATE - Hypoport AG

SAVE THE DATE - Hypoport AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Recticel<br />

Belgium/Chemicals Analyser<br />

Recticel (Hold)<br />

Hold<br />

Recommendation unchanged<br />

Share price: EUR<br />

closing price as of 07/05/2012<br />

Target price: EUR<br />

Target Price unchanged<br />

Reuters/Bloomberg<br />

5.50<br />

6.00<br />

RECT.BR/REC BB<br />

Market capitalisation (EURm) 159<br />

Current N° of shares (m) 29<br />

Free float 61%<br />

Daily avg. no. trad. sh. 12 mth 31,931<br />

Daily avg. trad. vol. 12 mth (m) 0<br />

Price high 12 mth (EUR) 7.80<br />

Price low 12 mth (EUR) 3.80<br />

Abs. perf. 1 mth -2.14%<br />

Abs. perf. 3 mth 11.11%<br />

Abs. perf. 12 mth -27.82%<br />

Key financials (EUR) 12/11 12/12e 12/13e<br />

Sales (m) 1,378 1,359 1,408<br />

EBITDA (m) 89 90 103<br />

EBITDA margin 6.4% 6.7% 7.3%<br />

EBIT (m) 42 47 59<br />

EBIT margin 3.0% 3.5% 4.2%<br />

Net Profit (adj.)(m) 17 22 31<br />

ROCE 6.1% 6.6% 8.0%<br />

Net debt/(cash) (m) 150 159 153<br />

Net Debt/Equity 0.6 0.6 0.5<br />

Debt/EBITDA 1.7 1.8 1.5<br />

Int. cover(EBITDA/Fin. int) 6.7 7.8 8.8<br />

EV/Sales 0.2 0.2 0.2<br />

EV/EBITDA 3.4 3.7 3.2<br />

EV/EBITDA (adj.) 3.4 3.7 3.2<br />

EV/EBIT 7.2 7.2 5.6<br />

P/E (adj.) 7.6 7.2 5.1<br />

P/BV 0.5 0.6 0.6<br />

OpFCF yield 25.7% 25.1% 26.0%<br />

Dividend yield 5.1% 5.5% 6.4%<br />

EPS (adj.) 0.60 0.76 1.07<br />

BVPS 8.60 9.08 9.85<br />

DPS 0.28 0.30 0.35<br />

8.0vvdsvdvsdy<br />

7.5<br />

7.0<br />

6.5<br />

6.0<br />

5.5<br />

5.0<br />

4.5<br />

4.0<br />

3.5<br />

Apr 11 May 11 Jun 11 Jul 11 Aug 11 Sep 11 Oct 11 Nov 11 Dec 11 Jan 12 Feb 12 Mar 12 Apr 12 May 12<br />

RECTICEL Belgium All Share (Rebased)<br />

Shareholders: Cie Bois Sauvage 29%;<br />

Sihold/Vean/Lennart/Sallas 9%; Rec-Man<br />

1.02%;<br />

Analyst(s):<br />

Bernard Hanssens, Bank Degroof<br />

bernard.hanssens@degroof.be<br />

+32 (0) 2 287 9689<br />

Weak 1Q12 trading update<br />

The facts: This morning Recticel released a weak 1Q12 trading update, with<br />

consolidated sales down 2.4% to EUR 351.1m. EBITDA margin seems on track<br />

with consensus estimates for FY12, but a new round of raw material price<br />

increases is ongoing in 2Q12.<br />

Our analysis: Sales dropped in all segments, with the exception of the insulation<br />

BU.<br />

Sales (EUR m) 1Q11 2Q11 3Q11 4Q11 FY11 1Q12 % chg<br />

Flexible Foams 159.8 142.4 147.3 146.6 596.1 157.4 -1.5%<br />

Bedding 78.9 62.7 76.8 73.8 292.2 73.6 -6.7%<br />

Insulation 48.4 60.2 54.8 59.7 223.1 53.0 9.5%<br />

Automotive 88.1 87.0 74.3 75.4 324.8 82.4 -6.4%<br />

Coporate/interco -15.6 -12.2 -16.6 -13.7 -58.1 -15.4 -1.3%<br />

Total 359.6 340.1 336.6 341.8 1,378.1 351.1 -2.4%<br />

Sources: Recticel<br />

In Flexible foams, sales held quite well. They are down 1.5% only, we guess<br />

thanks to some costs passed on.<br />

In Bedding, sales are down 6.7% mainly driven by weak performance in the nonbranding<br />

segment.<br />

In Automotive, sales decreased 6.5%, which is slightly better than the drop in car<br />

sales in Europe in 1Q12. The sub-segment Interiors saw sales down 11% as some<br />

running programs approach their phase-out stage.<br />

In Insulation, sales are up 9.5%, despite difficult climatic conditions in February.<br />

In 1Q12 raw material prices have been at levels comparable to those of the first<br />

quarter of 2011 and have been quickly rising as last year. It is our understanding<br />

that year-to-date raw material costs are up by a high single digit.<br />

However, management indicated that despite lower sales in most segments the<br />

overall profitability was in line with consensus expectations for FY12<br />

(EBITDA margin to sales of about 6.5%). This is due to the progressive passthrough<br />

of the higher raw material costs into the selling prices. However, there<br />

were further price increases in April and other price hikes announced for<br />

May. This explains why management is reluctant to provide any guidance for<br />

FY12.<br />

Conclusion & Action: No major surprises in this 1Q12 trading update. This<br />

changes little in our view on the company.<br />

The valuation is not demanding based on short term multiples (P/E of<br />

EV/EBITDA), but it is still hard to find triggers that could justify a re-rating in the<br />

coming months. This is due to the poor visibility on earnings and on the outcome<br />

of the antitrust investigations that could cost up to EUR 3.17 per share (we<br />

discount EUR 1.56 per share in our valuation). HOLD.<br />

Page 70 of 80 European Securities Network<br />

Please refer to important disclaimer on the last page

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!